Which question is the study trying to answer?
Ask the coordinator to explain the purpose in ordinary language and distinguish the research question from your own treatment goals. The study might observe experiences, collect assessments or evaluate a medicine, psychological approach or another procedure. The protocol determines what is actually involved. Ask whether it concerns schizophrenia specifically or a broader group, rather than treating all psychosis-related research as interchangeable. Clarify what is known and what remains uncertain about any intervention. A listing and its title can help you find questions, but do not establish benefit or suitability for your circumstances.
What would happen during and between appointments?
Request a schedule showing visits, assessments, any samples or monitoring, and tasks at home. Ask which activities require travel and how long appointments may take. If an interview or test is mentioned, ask what it involves before agreeing to the procedure. Explain practical constraints such as transport, work, study or support commitments. Ask about changes to appointments and the route for questions between them. There is no single schizophrenia-research schedule you can infer from the diagnosis. The written plan should describe the actual demands of this study.
Can information be explained in a way that works for you?
Ask for clear language, written notes, time to read, repetition or another conversation if useful. You can explain a preference without needing to prove a difficulty. A chosen supporter may help with questions or remembering information, depending on your wishes and the centre’s arrangements. Ask what can be discussed privately. Support with understanding should help your decision rather than replace it. If legal representation is relevant, ask the team about the particular requirements: being someone’s relative or chosen companion is not the same role. Do not infer capacity or incapacity from a diagnosis label alone.
How would usual medicines and care be handled?
Ask whether the study is compatible with current medicines, therapy, clinician appointments and other conditions. If it proposes a treatment requirement, ask why it matters, who would supervise any change and what alternatives exist. Discuss those questions with the study clinician and your usual care team. Do not stop or change medication to qualify for research. Ask who is responsible for prescriptions and care during gaps between research visits. Participation should be considered with an understandable account of how care is organised, rather than an assumption that the research team takes over everything.
What if symptoms or support needs change?
Ask what changes the team wants you to report, through which contact and at what hours. Discuss how it reviews safety, practical adjustments or whether particular activities should continue. Do not assume a missed visit or a difficult day has one automatic consequence. Ask the team to explain its actual process and how it coordinates with relevant clinicians. A study portal may not be monitored continuously; agree on separate urgent-care routes. If your situation changes before joining, tell the team through its verified private process so it can reassess the relevant criteria.
What should you know about privacy and care afterwards?
Find out who can see interviews, test results, recordings or app information, if those are used. Ask what can be shared with a supporter and what choices you have about optional activities. Discuss how you could stop participation and organise a clinician-led treatment transition if relevant. Before joining, ask who will provide care when the study ends and how overall results will be communicated. You can take a short question list to the appointment and write down the agreed contact and next step. This is preparation for a discussion, not a diagnostic checklist or a treatment recommendation.